Immunodominant Antiviral vs. Antitumor T Cell Responses in Oncolytic Virotherapy

Experimental data from a study investigating how immunodominant antiviral T cell responses can outcompete antitumor immunity during oncolytic virotherapy. The dataset, 10.1 GB in size, was created by Benjamin Kendall and last updated in June 2026. It includes results from experiments using Vesicular Stomatitis Virus (VSV) and combination therapy with αPD1 checkpoint blockade.

Use Cases

• Modeling T cell competition dynamics based on the described antiviral versus antitumor response paradigm.
• Evaluating the impact of αPD1 checkpoint blockade when combined with oncolytic viruses expressing tumor antigens.
• Analyzing the effect of mutant near-self tumor-associated antigens on breaking central tolerance and promoting heteroclitic T cell expansion.

Strengths

• Dataset is large at 10.1 GB, suggesting substantial experimental data.
• Includes data from multiple experimental conditions, such as VSV alone and in combination with αPD1 therapy.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Benjamin Kendall

Collection Method

Likely contains experimental results from immunological assays and animal models described in the study.

Freshness

Last updated 2026-06-01 23:07:53